Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Bader, Michael Prof. Dr. (2) Blankenstein, Thomas Prof. Dr. (21) Daniel, Peter Prof. Dr. (1) Edes, Inan Dr. (1) Hodge, Russell (1) Ittermann, Bernd Dr. (3) Kammertöns, Thomas Dr. (4) Kettenmann, Helmut Prof. Dr. (2) Kieback, Elisa Dr. (2) Klix, Sabrina (1) Kopp, Joachim Dr. (2) Ku, Min-Chi Dr. (2) Münchberg, Stefanie (1) Niendorf, Thoralf Prof. Dr. (38) Paul, Friedemann Prof. Dr. med. (7) Pezzutto, Antonio Prof. Dr. (3) Popova, Elena Dr. (1) Qadri, Fatimunnisa Dr. (1) Reimann, Henning Dr. (1) Schlag, Peter M. Prof. Dr. (1) Schulz-Menger, Jeanette Prof. Dr. (8) Todiras, Mihail (1) Waiczies, Helmar Dr. (8) Waiczies, Sonia PD Dr. (10) Winter, Lukas Dr. (5) Wolf, Susanne Dr. (2) (-) Bunse, Mario Dr. (1) (-) Leisegang, Matthias Prof. Dr. rer. nat. (3) (-) Uckert, Wolfgang Prof. Dr. (7) (-) Willimsky, Gerald Dr. (7) Bioinformatik der Genregulation (1) (-) Experimentelle Ultrahochfeld-MR (6) Genetik metabolischer und reproduktiver Störungen (3) Genom-Editierung & Krankheitsmodelle (2) Genomics (1) Immunregulation und Krebs (3) Magnetic Resonance (6) Mobile DNA (2) (-) Molekulare Immunologie und Gentherapie (13) Proteom Dynamik (1) RNA Biologie und Posttranscriptionale Regulation (1) Transgenics (2) Translationale Onkologie solider Tumore (1) Zelluläre Neurowissenschaften (5) 1997 (1) 1998 (1) 2000 (3) 2002 (1) 2003 (4) 2004 (1) 2005 (7) 2006 (1) 2007 (4) (-) 2008 (3) (-) 2010 (5) (-) 2011 (4) 2012 (2) 2013 (6) 2014 (3) 2015 (5) (-) 2016 (7) 2017 (5) 2018 (7) 2019 (2) 2020 (3) 2021 (1) 2022 (3) 2023 (2) 19 Ergebnisse: Active Filter: Bunse, Mario Dr.Leisegang, Matthias Prof. Dr. rer. nat.Uckert, Wolfgang Prof. Dr.Willimsky, Gerald Dr.Experimentelle Ultrahochfeld-MRMolekulare Immunologie und Gentherapie 2008201020112016 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 07. Juli 2008 / J Exp Med Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness G. Willimsky M. Czeh C. Loddenkemper J. Gellermann K. Schmidt P. Wust H. Stein T. Blankenstein 01. Oktober 2008 / Int J Cancer SV40 large T antigen-transformed human primary normal and cancerous mammary epithelial cells are phenotypically similar but can be distinguished in 3D culture with selection medium L.P. Li G. Willimsky S. Seitz Y. Xu Y. Li L.E. Schwarz P.M. Schlag T. Blankenstein 15. Januar 2008 / Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert 15. März 2010 / J Immunol In vivo imaging of an inducible oncogenic tumor antigen visualizes tumor progression and predicts CTL tolerance C. Buschow J. Charo K. Anders C. Loddenkemper A. Jukica W. Alsamah C. Perez G. Willimsky T. Blankenstein 01. Oktober 2011 / Eur Radiol Development and evaluation of a small and mobile Magneto Alert Sensor (MALSE) to support safety requirements for magnetic resonance imaging C. Martin T. Frauenrath C. Oezerdem W. Renz T. Niendorf 16. Dezember 2010 / Oncogene The immune response to sporadic colorectal cancer in a novel mouse model M. Czeh C. Loddenkemper S. Shalapour C. Schoen S. Robine E. Goldscheid H. Stein T. Schueler G. Willimsky T. Blankenstein 01. März 2010 / Hum Gene Ther Phase I trial of an allogeneic gene-modified tumor cell vaccine (RCC-26/CD80/IL-2) in patients with metastatic renal cell carcinoma A. Buchner H. Pohla G. Willimsky B. Frankenberger R. Frank A. Baur-Melnyk M. Siebels C.G. Stief A. Hofstetter J. Kopp A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel 28. Juli 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein 01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto 01. September 2010 / Eur J Immunol Commensal microflora and interferon-gamma promote steady-state interleukin-7 production in vivo S. Shalapour K. Deiser O. Sercan J. Tuckermann K. Minnich G. Willimsky T. Blankenstein G.J. Haemmerling B. Arnold T. Schueler Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
07. Juli 2008 / J Exp Med Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness G. Willimsky M. Czeh C. Loddenkemper J. Gellermann K. Schmidt P. Wust H. Stein T. Blankenstein
01. Oktober 2008 / Int J Cancer SV40 large T antigen-transformed human primary normal and cancerous mammary epithelial cells are phenotypically similar but can be distinguished in 3D culture with selection medium L.P. Li G. Willimsky S. Seitz Y. Xu Y. Li L.E. Schwarz P.M. Schlag T. Blankenstein
15. Januar 2008 / Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert
15. März 2010 / J Immunol In vivo imaging of an inducible oncogenic tumor antigen visualizes tumor progression and predicts CTL tolerance C. Buschow J. Charo K. Anders C. Loddenkemper A. Jukica W. Alsamah C. Perez G. Willimsky T. Blankenstein
01. Oktober 2011 / Eur Radiol Development and evaluation of a small and mobile Magneto Alert Sensor (MALSE) to support safety requirements for magnetic resonance imaging C. Martin T. Frauenrath C. Oezerdem W. Renz T. Niendorf
16. Dezember 2010 / Oncogene The immune response to sporadic colorectal cancer in a novel mouse model M. Czeh C. Loddenkemper S. Shalapour C. Schoen S. Robine E. Goldscheid H. Stein T. Schueler G. Willimsky T. Blankenstein
01. März 2010 / Hum Gene Ther Phase I trial of an allogeneic gene-modified tumor cell vaccine (RCC-26/CD80/IL-2) in patients with metastatic renal cell carcinoma A. Buchner H. Pohla G. Willimsky B. Frankenberger R. Frank A. Baur-Melnyk M. Siebels C.G. Stief A. Hofstetter J. Kopp A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel
28. Juli 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein
01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto
01. September 2010 / Eur J Immunol Commensal microflora and interferon-gamma promote steady-state interleukin-7 production in vivo S. Shalapour K. Deiser O. Sercan J. Tuckermann K. Minnich G. Willimsky T. Blankenstein G.J. Haemmerling B. Arnold T. Schueler